PMC:7795856 / 90-395 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"18","span":{"begin":38,"end":41},"obj":"Gene"},{"id":"20","span":{"begin":96,"end":113},"obj":"Species"},{"id":"24","span":{"begin":115,"end":118},"obj":"Species"},{"id":"31","span":{"begin":124,"end":158},"obj":"Disease"},{"id":"32","span":{"begin":237,"end":245},"obj":"Disease"},{"id":"33","span":{"begin":246,"end":256},"obj":"Disease"},{"id":"34","span":{"begin":261,"end":267},"obj":"Disease"}],"attributes":[{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Gene:134864"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:10407"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:10407"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D006526"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:C000657245"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D007239"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"y and Virology\n\nAbstract\nThymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer. Manufacturing of this N-terminally a"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":96,"end":105},"obj":"Phenotype"},{"id":"T3","span":{"begin":124,"end":133},"obj":"Phenotype"},{"id":"T4","span":{"begin":261,"end":267},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0012115"},{"id":"A4","pred":"hp_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"y and Virology\n\nAbstract\nThymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer. Manufacturing of this N-terminally a"}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":16,"end":24},"obj":"Sentence"},{"id":"T4","span":{"begin":25,"end":268},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"y and Virology\n\nAbstract\nThymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer. Manufacturing of this N-terminally a"}